Keeping Drugs Out of Schools Act of 2025
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Keeping Drugs Out of Schools Act of 2025, changes federal law or congressional policy affecting schools, students, and education providers. The main policy domain is Education, Healthcare, Energy.
Who Benefits and How
schools, students, and education providers may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, schools, students, and education providers may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H9127633913764B2880BA6756D4AE80EE: 1. Short title This Act may be cited as the Keeping Drugs Out of Schools Act of 2025.
- Section HB587DCD8B0354EF991046C7A8E37E6D5: 2. Grant program In this section: The term Director means the Director of the Office of National Drug Control Policy. The term Drug-Free Communities funded...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Keeping Drugs Out of Schools Act of 2025, changes federal law or congressional policy affecting schools, students, and education providers.
Key Policy Areas
Education, Healthcare, Energy
Primary Purpose
This bill, Keeping Drugs Out of Schools Act of 2025, changes federal law or congressional policy affecting schools, students, and education providers.
Policy Domains
Whole bill
Identified Gains
- schools, students, and education providers
Identified Costs
- federal implementing agencies
- schools, students, and education providers
Sponsors
Legislative Progress
In CommitteeMs. Sánchez (for herself and Mr. Lawler) introduced the following …
Referred to the House Committee on Energy and Commerce.
Introduced in House
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
Key Definitions
Terms defined in this bill
a coalition (within the meaning of section 1032 of the Anti-Drug Abuse Act of 1988 (21 U.S.C. 1532)) that— receives or has received a grant under subchapter I of chapter 2 of title I of the Anti-Drug Abuse Act of 1988 (21 U.S.C. 1523 et seq.)
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology